Camlin Fine Sciences · NSE: CAMLINFINE · BSE: 532834
Q2 FY21 results · Jul–Sep 2020
Camlin Fine Sciences reported revenue from operations of ₹256.81 crore (up 15.5% from Q2 FY20) and net profit of ₹9.66 crore (up 28.5% from Q2 FY20) for Q2 FY21 (Jul–Sep 2020), on a consolidated basis.
| Item | Q2 FY21 | Q2 FY20 | YoY | Q1 FY21 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 256.81 | 222.28 | +15.5% | 305.74 | −16.0% |
| Other income | 1.28 | 0.64 | +100.0% | 0.47 | +175.0% |
| Total income | 258.09 | 222.92 | +15.8% | 306.21 | −15.7% |
| Profit before tax | 17.17 | 8.56 | +100.6% | 31.51 | −45.5% |
| Net profit for the period | 9.66 | 7.52 | +28.5% | 20.56 | −53.0% |
| Attributable to shareholders of the company | 5.89 | 6.94 | −15.1% | 15.39 | −61.7% |
| EPS, basic (₹) | 0.49 | 0.57 | −14.0% | 1.27 | −61.4% |
| Net margin (%) | 3.8 | 3.4 | 6.7 |
| Item | Q2 FY21 | Q2 FY20 | YoY | Q1 FY21 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 146.78 | — | — | 121.17 | +21.1% |
| Other income | 1.33 | — | — | 0.99 | +33.8% |
| Total income | 148.10 | — | — | 122.16 | +21.2% |
| Profit before tax | (0.88) | — | — | 5.10 | Turned loss |
| Net profit for the period | (1.02) | — | — | 3.81 | Turned loss |
| EPS, basic (₹) | (0.08) | — | — | 0.31 | Turned loss |
| Net margin (%) | -0.7 | — | 3.1 |
Consolidated
- Filed with BSE
- 18 Nov 2020, 17:42 IST
- Board meeting
- 12 Nov 2020
- Period
- 01 Jul 2020 to 30 Sep 2020
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 18 Nov 2020, 17:42 IST
- Board meeting
- 12 Nov 2020
- Period
- 01 Jul 2020 to 30 Sep 2020
- Review status
- Unaudited
- Source
- XBRL filing on BSE